252 related articles for article (PubMed ID: 21087211)
21. ERK/RSK-mediated phosphorylation of Y-box binding protein-1 aggravates diabetic cardiomyopathy by suppressing its interaction with deubiquitinase OTUB1.
Zhong X; Wang T; Zhang W; Wang M; Xie Y; Dai L; He X; Madhusudhan T; Zeng H; Wang H
J Biol Chem; 2022 Jun; 298(6):101989. PubMed ID: 35490780
[TBL] [Abstract][Full Text] [Related]
22. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
[TBL] [Abstract][Full Text] [Related]
23. Role of p90(RSK) in regulating the Crabtree effect: implications for cancer.
Redman EK; Brookes PS; Karcz MK
Biochem Soc Trans; 2013 Feb; 41(1):124-6. PubMed ID: 23356270
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A.
Wu J; Janknecht R
J Biol Chem; 2002 Nov; 277(45):42669-79. PubMed ID: 12213813
[TBL] [Abstract][Full Text] [Related]
25. A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65.
Zhang L; Ma Y; Zhang J; Cheng J; Du J
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1148-53. PubMed ID: 15802625
[TBL] [Abstract][Full Text] [Related]
26. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2.
Goetze S; Kintscher U; Kaneshiro K; Meehan WP; Collins A; Fleck E; Hsueh WA; Law RE
Atherosclerosis; 2001 Nov; 159(1):93-101. PubMed ID: 11689211
[TBL] [Abstract][Full Text] [Related]
27. Rapid Dynamics of Signal-Dependent Transcriptional Repression by Capicua.
Keenan SE; Blythe SA; Marmion RA; Djabrayan NJ; Wieschaus EF; Shvartsman SY
Dev Cell; 2020 Mar; 52(6):794-801.e4. PubMed ID: 32142631
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.
Sananbenesi F; Fischer A; Schrick C; Spiess J; Radulovic J
Mol Cell Neurosci; 2002 Nov; 21(3):463-76. PubMed ID: 12498787
[TBL] [Abstract][Full Text] [Related]
29. The MAP kinase ERK5 binds to and phosphorylates p90 RSK.
Ranganathan A; Pearson GW; Chrestensen CA; Sturgill TW; Cobb MH
Arch Biochem Biophys; 2006 May; 449(1-2):8-16. PubMed ID: 16626623
[TBL] [Abstract][Full Text] [Related]
30. p90 activation contributes to cerebral ischemic damage via phosphorylation of Na+/H+ exchanger isoform 1.
Manhas N; Shi Y; Taunton J; Sun D
J Neurochem; 2010 Sep; 114(5):1476-86. PubMed ID: 20557427
[TBL] [Abstract][Full Text] [Related]
31. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation.
Roux PP; Shahbazian D; Vu H; Holz MK; Cohen MS; Taunton J; Sonenberg N; Blenis J
J Biol Chem; 2007 May; 282(19):14056-64. PubMed ID: 17360704
[TBL] [Abstract][Full Text] [Related]
32. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
Kawamura-Saito M; Yamazaki Y; Kaneko K; Kawaguchi N; Kanda H; Mukai H; Gotoh T; Motoi T; Fukayama M; Aburatani H; Takizawa T; Nakamura T
Hum Mol Genet; 2006 Jul; 15(13):2125-37. PubMed ID: 16717057
[TBL] [Abstract][Full Text] [Related]
33. RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance.
Ray-David H; Romeo Y; Lavoie G; Déléris P; Tcherkezian J; Galan JA; Roux PP
Oncogene; 2013 Sep; 32(38):4480-9. PubMed ID: 23108403
[TBL] [Abstract][Full Text] [Related]
34. The RSK factors of activating the Ras/MAPK signaling cascade.
Carriere A; Ray H; Blenis J; Roux PP
Front Biosci; 2008 May; 13():4258-75. PubMed ID: 18508509
[TBL] [Abstract][Full Text] [Related]
35. Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase.
Kosnopfel C; Sinnberg T; Sauer B; Niessner H; Schmitt A; Makino E; Forschner A; Hailfinger S; Garbe C; Schittek B
Oncotarget; 2017 May; 8(22):35761-35775. PubMed ID: 28415756
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of ERK-MAP kinase signaling by RSK during Drosophila development.
Kim M; Lee JH; Koh H; Lee SY; Jang C; Chung CJ; Sung JH; Blenis J; Chung J
EMBO J; 2006 Jul; 25(13):3056-67. PubMed ID: 16763554
[TBL] [Abstract][Full Text] [Related]
37. Brain-derived neurotrophic factor promotes vesicular glutamate transporter 3 expression and neurite outgrowth of dorsal root ganglion neurons through the activation of the transcription factors Etv4 and Etv5.
Liu D; Liu Z; Liu H; Li H; Pan X; Li Z
Brain Res Bull; 2016 Mar; 121():215-26. PubMed ID: 26876757
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
39. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.
Doehn U; Hauge C; Frank SR; Jensen CJ; Duda K; Nielsen JV; Cohen MS; Johansen JV; Winther BR; Lund LR; Winther O; Taunton J; Hansen SH; Frödin M
Mol Cell; 2009 Aug; 35(4):511-22. PubMed ID: 19716794
[TBL] [Abstract][Full Text] [Related]
40. Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3.
Galan JA; Geraghty KM; Lavoie G; Kanshin E; Tcherkezian J; Calabrese V; Jeschke GR; Turk BE; Ballif BA; Blenis J; Thibault P; Roux PP
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):E2918-27. PubMed ID: 25002506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
